Outcome of Board Meeting held on 8th August, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Limited's Board of Directors met on 8th August 2025 and approved three key items. First, the company will increase its authorised share capital marginally from Rs. 25 crore to Rs. 25.5 crore (an addition of Rs. 50 lakh), creating 5 lakh additional equity shares of Rs. 10 face value each. Second, the Board approved the Director's Report for FY2024-25 along with its annexures. Third, the 14th Annual General Meeting (AGM) has been scheduled for Saturday, 30th August 2025 at 4:00 PM, to be held via video conferencing. No dividend, bonus issue, stock split, buyback, or rights issue was announced in this filing.
This is a routine procedural filing with no material corporate action for shareholders. The authorised capital increase is minor and does not signal any immediate fundraising, dilution, or reward to shareholders. Investors should watch for the AGM notice and annual report for any substantive business updates or dividend announcements.